Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM7384938 |
untreated_1
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384939 |
untreated_2
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384940 |
untreated_3
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384941 |
untreated_5
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384942 |
untreated_6
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384943 |
Beta-glucan_1
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384944 |
Beta-glucan_2
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384945 |
Beta-glucan_3
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384946 |
Beta-glucan_4
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384947 |
Beta-glucan_5
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384948 |
Beta-glucan_6
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384949 |
anti-CD40_1
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384950 |
anti-CD40_2
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384951 |
anti-CD40_3
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384952 |
anti-CD40_4
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384953 |
anti-CD40_5
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384954 |
anti-CD40_6
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384955 |
Beta-glucan/anti-CD40_1
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384956 |
Beta-glucan/anti-CD40_2
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 | |||
GSM7384957 |
Beta-glucan/anti-CD40_3
|
SRA | 1 |
|
Max M Wattenberg | Nov 10, 2023 |